Cerebrospinal fluid biomarkers in neurological diseases in children

European Journal of Paediatric Neurology

Volumn 17, Issue 1, 2013, Pages 7-13

  Shahim, Pashtun ^a   Månsson, Jan Eric ^a   Darin, Niklas ^b   Zetterberg, Henrik ^a   Mattsson, Niklas ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Amyloid ; Biomarkers; Cerebrospinal fluid; Children; GFAP; Neurodegeneration; Neurofilament; Tau

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT LIGHT PROTEIN; NEUROFILAMENT PROTEIN; NEURON SPECIFIC ENOLASE; S 100 CALCIUM BINDING PROTEIN BETA; TAU PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT DISEASE; AGE DISTRIBUTION; BLOOD BRAIN BARRIER; BRAIN METABOLISM; CEREBROSPINAL FLUID ANALYSIS; CHILDHOOD DISEASE; CLINICAL PRACTICE; DISEASE MARKER; HUMAN; LEUKOCYTE COUNT; NERVE CELL; NERVE FIBER; NERVE INJURY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW;

BIOLOGICAL MARKERS; CEREBROSPINAL FLUID; CHILD; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 84872103549     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2012.09.005     Document Type: Review

References (80)

1. H. Quincke Die Technik der Lumbalpunction 1902 Urban & Schwarzenberg Berlin 15 pp.
2. J.A. Frederiks, and P.J. Koehler The first lumbar puncture J Hist Neurosci 6 2 1997 147 153
3. K. Hyland Neurochemistry and defects of biogenic amine neurotransmitter metabolism J Inherit Metab Dis 22 4 1999 353 363
4. K.J. Swoboda, and K. Hyland Diagnosis and treatment of neurotransmitter-related disorders Neurol Clin 20 4 2002 1143 1161 viii
5. I. Marin-Valencia Biochemical diagnosis of dopaminergic disturbances in paediatric patients: analysis of cerebrospinal fluid homovanillic acid and other biogenic amines Clin Biochem 41 16-17 2008 1306 1315
6. N. Longo Disorders of biopterin metabolism J Inherit Metab Dis 32 3 2009 333 342
7. M. Serrano Kearns-Sayre syndrome: cerebral folate deficiency, MRI findings and new cerebrospinal fluid biochemical features Mitochondrion 10 5 2010 429 432
8. A. Ormazabal Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid Neuropediatrics 36 6 2005 380 385
9. N. Blau Cerebrospinal fluid pterins and folates in Aicardi-Goutieres syndrome: a new phenotype Neurology 61 5 2003 642 647
10. S. Mangold Cerebral folate deficiency: a neurometabolic syndrome? Mol Genet Metab 104 3 2011 369 372
11. R.A. Wevers A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC) J Inherit Metab Dis 22 4 1999 364 373
12. L. Brun Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency Neurology 75 1 2010 64 71
13. M. Dahlin, J.E. Mansson, and P. Amark CSF levels of dopamine and serotonin, but not norepinephrine, metabolites are influenced by the ketogenic diet in children with epilepsy Epilepsy Res 99 1-2 2012 132 138
14. B.A. Shaywitz, D.J. Cohen, and M.B. Bowers Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy Neurology 25 1 1975 72 79
15. M.R. Pranzatelli Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus Mov Disord 13 3 1998 522 528
16. P.J. Langlais, M.L. Wardlow, and H. Yamamoto Changes in CSF neurotransmitters in infantile spasms Pediatr Neurol 7 6 1991 440 445
17. M. Giroud 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of children with febrile convulsions Epilepsia 31 2 1990 178 181
18. A. Habel Homovanillic acid and 5-hydroxyindoleacetic acid in lumbar cerebrospinal fluid in children with afebrile and febrile convulsions Neurology 31 4 1981 488 491
19. K. Blennow Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat Rev Neurol 6 3 2010 131 144
20. M.S. Albert The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 3 2011 270 279
21. G.M. McKhann The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 3 2011 263 269
22. F. Dubos Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis J Pediatr 149 1 2006 72 76
23. M. Djukic Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis J Neurol 259 4 2012 630 636
24. F. Deisenhammer Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force Eur J Neurol 13 9 2006 913 922
25. B. Hagberg, P. Sourander, and L. Svennerholm Diagnosis of Krabbe's infantile leucodystrophy J Neurol Neurosurg Psychiatry 26 1963 195 198
26. M. Vandermeeren Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay J Neurochem 61 5 1993 1828 1834
27. J.Q. Trojanowski Distribution of tau proteins in the normal human central and peripheral nervous system J Histochem Cytochem 37 2 1989 209 215
28. M. Morris The many faces of tau Neuron 70 3 2011 410 426
29. K. Muszynska-Roslan Level of tau protein in children treated for acute lymphoblastic leukemia Pediatr Neurol 34 5 2006 367 371
30. J.M. de Bont Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients Eur J Paediatr Neurol 12 4 2008 334 341
31. D. Gavhed Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis Pediatr Blood Cancer 53 7 2009 1264 1270
32. I.M. Medana, R. Idro, and C.R. Newton Axonal and astrocyte injury markers in the cerebrospinal fluid of Kenyan children with severe malaria J Neurol Sci 258 1-2 2007 93 98
33. K. Rostasy Tau, phospho-tau, and S-100B in the cerebrospinal fluid of children with multiple sclerosis J Child Neurol 20 10 2005 822 825
34. A. Holownia Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol Acta Haematol 112 4 2004 222 224
35. S.W. Van Gool Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies Leukemia 14 12 2000 2076 2084
36. N. Tanuma The axonal damage marker tau protein in the cerebrospinal fluid is increased in patients with acute encephalopathy with biphasic seizures and late reduced diffusion Brain Dev 32 6 2010 435 439
37. G.W. Kay Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease) Neurochem Int 55 8 2009 783 788
38. N. Mattsson Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a cross-sectional study Neurology 76 4 2011 366 372
39. N. Mattsson Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in Niemann-Pick type C. JIMD Reports 3 2011 45 52
40. I.A. Auer Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease Acta Neuropathol 90 6 1995 547 551
41. K. Blennow, and H. Hampel CSF markers for incipient Alzheimer's disease Lancet Neurol 2 10 2003 605 613
42. N. Mattsson Converging molecular pathways in human neural development and degeneration Neurosci Res 66 3 2010 330 332
43. R.L. Friede, and T. Samorajski Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice Anat Rec 167 4 1970 379 387
44. I.V. Mersiyanova A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene Am J Hum Genet 67 1 2000 37 46
45. R. Kristjansdottir, P. Uvebrant, and L. Rosengren Glial fibrillary acidic protein and neurofilament in children with cerebral white matter abnormalities Neuropediatrics 32 6 2001 307 312
46. L.F. Eng An acidic protein isolated from fibrous astrocytes Brain Res 28 2 1971 351 354
47. A. Bignami Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence Brain Res 43 2 1972 429 435
48. M. Kyllerman Increased levels of GFAP in the cerebrospinal fluid in three subtypes of genetically confirmed Alexander disease Neuropediatrics 36 5 2005 319 323
49. N. Gordon Alexander disease Eur J Paediatr Neurol 7 6 2003 395 399
50. G. Osterlundh Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children Pediatr Blood Cancer 50 4 2008 793 798
51. C.A. Gurnett, M. Landt, and M. Wong Analysis of cerebrospinal fluid glial fibrillary acidic protein after seizures in children Epilepsia 44 11 2003 1455 1458
52. S.W. Barger, L.J. Van Eldik, and M.P. Mattson S100 beta protects hippocampal neurons from damage induced by glucose deprivation Brain Res 677 1 1995 167 170
53. W.S. Griffin Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease Proc Natl Acad Sci U S A 86 19 1989 7611 7615
54. J. Zurek, and M. Fedora The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury Acta Neurochir (Wien) 154 1 2012 93 103 discussion 103
55. F.S. Esch Cleavage of amyloid beta peptide during constitutive processing of its precursor Science 248 4959 1990 1122 1124
56. K. Blennow, M.J. de Leon, and H. Zetterberg Alzheimer's disease Lancet 368 9533 2006 387 403
57. L.W. Jin Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities Am J Pathol 164 3 2004 975 985
58. H. Englund Increase in beta-amyloid levels in cerebrospinal fluid of children with Down syndrome Dement Geriatr Cogn Disord 24 5 2007 369 374
59. C. Ortez Undetectable levels of CSF amyloid-beta peptide in a patient with 17beta-hydroxysteroid dehydrogenase deficiency J Alzheimers Dis 27 2 2011 253 257
60. D. Strozyk CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study Neurology 60 4 2003 652 656
61. A.M. Fagan Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans Ann Neurol 59 3 2006 512 519
62. J.R. Slemmon Measurement of Abeta1-42 in cerebrospinal fluid is influenced by matrix effects J Neurochem 120 2 2012 325 333
63. E.H. Chang AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice Proc Natl Acad Sci U S A 103 9 2006 3410 3415
64. F. Kamenetz APP processing and synaptic function Neuron 37 6 2003 925 937
65. P. Wasling Synaptic retrogenesis and amyloid-beta in Alzheimer's disease J Alzheimers Dis 16 1 2009 1 14
66. M. Bothwell, and E. Giniger Alzheimer's disease: neurodevelopment converges with neurodegeneration Cell 102 3 2000 271 273
67. R. Kristjansdottir Cerebrospinal fluid markers in children with cerebral white matter abnormalities Neuropediatrics 32 4 2001 176 182
68. N. Norgren Neurofilament and glial fibrillary acidic protein in multiple sclerosis Neurology 63 9 2004 1586 1590
69. T. Avsar Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis Mult Scler 18 8 2012 1081 1091
70. M. Axelsson Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis J Neurol 258 5 2011 882 888
71. R.J. Bateman Clinical and biomarker changes in dominantly inherited Alzheimer's disease N Engl J Med 367 9 2012 795 804
72. M. Gunnarsson Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab Ann Neurol 69 1 2011 83 89
73. K. Blennow Effect of immunotherapy with Bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease Arch Neurol 69 8 2012 1002 1010
74. A. Perret-Liaudet Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubes J Alzheimers Dis 31 1 2012 13 20
75. M. Tullberg Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus Eur J Neurol 14 3 2007 248 254
76. A. Olsson Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology Clin Chem 51 2 2005 336 345
77. A. Petzold Neurofilament ELISA validation J Immunol Methods 352 1-2 2010 23 31
78. N. Mattsson The Alzheimer's association external quality control program for cerebrospinal fluid biomarkers Alzheimers Dement 7 4 2011 386 395.e6
79. M. Blennow Glial fibrillary acidic protein is increased in the cerebrospinal fluid of preterm infants with abnormal neurological findings Acta Paediatr 85 4 1996 485 489
80. L.E. Rosengren A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children J Neurosci Methods 44 2-3 1992 113 119